Digital Mental Health and AI

The afternoon talks include:

• PsyMetRic-Using digital tools to identify cardiometabolic risk in early psychosis
  Dr Shuqing Si, Research Fellow, Institute for Mental Health, University of Birmingham
  
  Talk synopsis:
  
  Physical health problems are often overlooked in people with psychosis, despite their huge impact on quality of life and long-term outcomes. Among these, cardiometabolic abnormalities - which can be detectable from illness onset - are significant, influenced by lifestyle, genetic, and treatment factors. In the era of big data, predictive digital tools offer valuable opportunities to support earlier identification and intervention for cardiometabolic risk in psychosis.
  PsyMetRiC is a risk prediction tool developed and validated across multiple international sites to estimate the short- and long-term risk of developing cardiometabolic comorbidities in young people with early psychosis. In this talk, we will introduce the development of PsyMetRiC from biostatistical equation to medical device that can be trusted by health professionals, and discuss how it can enhance communication between healthcare professionals and patients, and improve shared decision making of physical health in psychosis.
   
• Advancing Early Intervention in Psychosis: Insights from the CONNECT study
  Professor Sandra Bucci,  NIHR Research Professor and Professor of Clinical Psychology, University of Manchester; Honorary Consultant Clinical Psychologist and Co-Director, Complex Trauma and Resilience Research Unit,  Greater Manchester Mental Health NHS FT
  
  Talk synopsis:
  
  In this talk, Professor Bucci will present the Wellcome Trust-funded CONNECT study, the world’s largest digital biomarker study for predicting psychosis relapse. Focusing on how cutting-edge digital tools can detect early signs of relapse, the session will explore the transformative potential of technology in providing real-time support and enabling early intervention. Attendees will gain insights into how digital innovation is impacting mental health care, offering new pathways for prevention, and personalised treatment people with psychosis.
   
• The future of Psychiatry - AI Agents and Scribes as your new Virtual Assistants
  Dr Peter Yellowlees, Director UCD/UCI Fellowship in Wellbeing, Distinguished Professor of Psychiatry, Dept of Psychiatry and Behavioral Sciences, UC Davis, California 

  Lecture Summary:

  The practice of psychiatry is already changing dramatically post-Covid with the increase in digital mental health tools, especially tele psychiatry. The next wave of change will be the use of Artificial Intelligence which will be increasingly integrated into clinical practice over the next several years. This talk will focus on the use of AI Agents, to automatically interview patients, and AI scribes and ambient AI systems, to draft initial psychiatric notes, markedly reducing time needed by psychiatrists for interviewing and documentation. These AI “virtual assistants” are taking up roles that are similar to those occupied by trainee psychiatrists - they interview and document histories in advance of the psychiatrist seeing the patient - except that they never forget a question or miss documenting an important part of the history. Demonstrations of these AI tools which are already being used in clinical practice will be part of the presentation.
   
• Further speaker to be confirmed 

CPD Certificates will be given to attendees.

You will be able to submit questions to the speaker during the event using the Q&A function on Zoom.